The producer of medical marijuana from ?ód? will enter the stock exchange
CanPoland SA is a company from the pharmaceutical industry, a leading Polish exporter of medical marijuana. The company is currently launching its own plant in ?ód? producing pharmaceutical raw material based on non-fiber hemp. Due to the ambitious development strategy, the CanPoland SA plans to obtain additional financing. First in the investment crowdfunding formula, and then through the issue of shares on New Connect WSE.
CanPoland SA is a pharmaceutical company with Polish capital that has permits to trade in medicinal products based on cannabis (i.e. medical marijuana) in Poland and to sell it to foreign recipients. The company also deals with repackaging services and wholesale of drugs, but its strategic goal is to produce medical marijuana in its own production plant, which has been legal in Poland since 2017.
The company has designed and finished the preparation of an internationally unique hybrid machine for the production of medical marijuana, which is able to produce pharmaceutical raw materials in the form of both flowers and oils. It has signed three gas supply contracts with the EU, Canada, and Africa. The production line will be installed in March this year. - We are currently in the testing phase. It was designed for a year and so far the value of our investments in machines has amounted to approximately PLN 3 million. These expenditures are returned to us, because thanks to the innovations applied within one technological line, we will be able to produce raw materials not only from flowers but also in the form of oils - said Bart?omiej Wasilewski, President of the Management Board and co-founder of CanPoland SA.
The minority shareholder of CanPoland SA is TT Pharma Sp. z o.o. belonging to the Pelion Group, i.e. one of the largest Polish companies in the healthcare sector with its headquarters in ?ód?. - Metaphorically, we can say that we have built a high-quality 'racing vehicle', which we are just introducing to the 'rally track' and where the only thing left to success is refueling and starting the fight. - said Zbigniew Pisarski, founder of CanPoland SA.
Pharmacy is the foundation of the ?ód? economy. CanPoland has a great chance to dominate the cannabis market that is just emerging. The production line concept was created in ?ód?, the product and its composition are developed in ?ód?, and marketing assumptions are created here. CanPoland is a very valuable entity - attractive cities are built on such workplaces and on such processes. In addition, I am pleased with the business synergies with the well-known Lodz company Pelion, which is valued for its reliability and innovation - emphasizes Adam Pustelnik, first vice president of the City of Lodz.
CanPoland employs about 30 people in ?ód? today. Due to the company's development, additional 70 employees are planned to be recruited soon. The company's headquarters, production plant and warehouse are located in ?ód?, and there is a sales office in Warsaw.
A crowdinvesting campaign on the Crowdway.pl platform will start soon, during which everyone will be able to invest in CanPoland SA, before the company debuts on the NewConnect market operated by the Warsaw Stock Exchange.